This is the limited version of the OSI Pharmaceuticals company profile: Join LinkedIn or Sign In to see more information.
OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high-quality, novel and differentiated personalized medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity.
We specialize in the discovery and development of innovative molecular targeted therapies that address significant unmet medical needs, and strive to turn pioneering science into breakthrough therapies for patients suffering from life-threatening diseases.
Your Connections to OSI Pharmaceuticals
Popular Profiles at OSI Pharmaceuticals
Last edited by Director, Corporate Training & Leadership Development
41 Pinelawn Road
Melville, New
York
United States
Phone: 631-962-2000
Fax: 631-752-3880
| Headquarters | Greater New York City Area |
|---|
| Industry | Pharmaceuticals |
|---|
| Type | Public Company |
|---|
| Status | Operating |
|---|
| Company Size |
550 employees
|
|---|
| 2006 Revenue |
$376
mil
(116%)
|
|---|
| Founded | 1983 |
|---|
| Website | http://www.osip.com |
|---|
| Top Schools |
| Univ. of Colorado at Boulder | 4% |
| Hofstra Univ. | 3% |
|
Estimated based on LinkedIn Data
Career path for OSI Pharmaceuticals employees
OSI Pharmaceuticals employees are most connected to
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about OSI Pharmaceuticals. This page is not endorsed by or affiliated with OSI Pharmaceuticals. For questions regarding LinkedIn Company Profiles, contact us.
Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
